Undiluted at $1.1 bil SOI at 2.9c SP and $2mil in the bank left, the EV here is now at $30 million.
EV still too high for what IAM has achieved to date imo.
I could not justify an entry here above an EV of $10 mil, maybe $15 mil if I believed the BOOM portal would bring significant improvements to IAM's cashflow, which I currently dont.
The good news is expenditure hasn't blown out, but it is still around $500,000 per quarter above cash in. This means that at current rates they will be under $1 mil cash in Q1 2018 and have to start thinking about a CR, so IAM have 6 months to turn things around.
This is not impossible imo, but they really need to stop with the podcasts and the IAMLTH site and the twitter rubbish. They need to focus on driving revenue.
- Forums
- ASX - By Stock
- CF1
- Ann: Appendix 4C - quarterly
CF1
complii fintech solutions ltd
Add to My Watchlist
0.00%
!
2.4¢

Ann: Appendix 4C - quarterly, page-4
-
- There are more pages in this discussion • 201 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.71M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 457248 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.5¢ | 505690 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 457248 | 0.022 |
1 | 250000 | 0.021 |
2 | 73125 | 0.020 |
3 | 912562 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.025 | 505690 | 1 |
0.026 | 500000 | 1 |
0.028 | 506514 | 2 |
0.029 | 113723 | 1 |
0.030 | 500000 | 1 |
Last trade - 10.00am 07/07/2025 (20 minute delay) ? |
Featured News
CF1 (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online